Funding Opportunities

Print Feedback

Font Size: + -

UCLA's Jonsson Comprehensive Cancer Center (JCCC) facilitates multiple funding opportunities. Intramural funding opportunities are divided into three programs: Seed Grants, Impact Grants and Fellowship Awars. Extramural funding opportunities are limited and applications are administered via the JCCC.

Intramural funding

To facilitate our intramural funding programs, we have established an external funding resource where you can learn about the different opportunities available to you, and download and submit applications.

Note that the previously previous UCLA CCLE funding collaborative environment has been sunsetted by UCLA as of November 17, 2022. We will be launching a new portal via UCLA Bruin Learn. This new application mechanism will launch in Spring 2023 for our next funding cycle. Please watch this page, which will be updated with information when it is announced.

Extramural funding

The following is a list of active extramural funding opportunities, provided as a courtesy to UCLA Jonsson Comprehensive Cancer Center members. To be included on this list, funding must be unlimited and applications be managed directly by the JCCC. If you have any questions about a specific opportunity listed below, please email Nancy Presseau at npresseau@mednet.ucla.edu.

Listings are generally updated on a monthly basis. Entries are ordered by posting date, with most recent postings first. Funding opportunities are removed from this list once their final application due date has passed.

POSTED OCTOBER 30, 2022

Sebastian Strong Foundation 2023 Discovery Science Award

Deadline: NIH biosketch due to JCCC: November 28, 2022 / final application due: January 11, 2023.

How to apply: Submit a one-page research summary and updated NIH biosketch to Genevieve Ortega-Alves via email.

Overview: The Sebastian Strong Foundation is especially interested in research focused on the following: general pediatric cancer; special pediatric cancers “without a high survival rate”; pediatric cancers with a low survival rate upon relapse; research projects that result in “less toxic” cures; research projects that can be understood by the foundation’s board and donors; research projects that may lead to a clinical trial in one to three years. Please note that peer-reviewed, new, ongoing, and updated research will be considered, and trials that are in progress and ongoing clinical trials will not be accepted.

NCCN Young Investigator Award

Deadline: Summary due to JCCC: November 14, 2022 by 5:00 p.m. PST / final application due: January 25, 2023.

How to apply: Submit a one-page summary of your research project and updated NIH biosketch to Genevieve Ortega-Alves via email.

Overview: Nominees must have:

Medical degree – MD, DO or international equivalent OR
Scientific degree – PhD or international equivalent
OR Nursing degree – Masters and above or international equivalent OR
Pharmacy degree – PharmD or international equivalent AND
Primary affiliation/work site at an NCCN Member Institution for the duration of the award period AND
First full-time appointment at an NCCN Member Institution and remain in good standing for the duration of the award period AND
Mentor in the proposed research field AND
Institutional commitment to support the research project

St. Baldrick's Foundation 2023

Deadline: Summary due to JCCC: October 31, 2022 / Selected LOI due: December 2, 2022.

How to apply: Submit letter of intent and updated NIH biosketch to Genevieve Ortega-Alves via email.

Overview: One applicant will be selected for each opportunity, when replying please indicate which opportunity, or opportunities, you are interested in. The St. Baldrick’s Foundation has a special interest in the following research categories: 1) Brain Tumors – all types, including rare forms; 2) Burkitt lymphoma (sporadic, endemic, and immunodeficiency related); 3) Complementary and alternative therapies; 4) Hepatoblastoma; 5) Langerhans Cell Histiocytosis; 6) Rhabdoid tumors.

The three St. Baldrick’s Foundation funding opportunities are:

POSTED SEPTEMBER 19, 2022

NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (Independent Clinical Trial Not Allowed)

Deadline: Research summary and biosketch due by November 4, 2022 / full application due: February 28, 2023.

How to apply: Please send a one-page research summary and your NIH Biosketch to Nancy Presseau at npresseau@mednet.ucla.edu.

Overview: The purpose of the NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators. This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees to launch competitive, independent research careers. Researchers in the scientific areas of data science and cancer control science are especially encouraged to work with their institutions to apply. For more information, visit the NCI website.

NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (Independent Clinical Trial Required)

Deadline: Research summary and biosketch due by November 4, 2022 / full application due: February 28, 2023.

How to apply: Please send a one-page research summary and your NIH Biosketch to Nancy Presseau at npresseau@mednet.ucla.edu.

Overview: The purpose of the NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators. This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees launch competitive, independent research careers. Researchers in the scientific areas of data science and cancer control science are especially encouraged to work with their institutions to apply.

For more information, visit the NCI website.

NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (Independent Basic Experimental Studies with Humans Required)

Deadline: Research summary and biosketch due by November 4, 2022 / full application due: February 28, 2023.

How to apply: Please send a one-page research summary and your NIH Biosketch to Nancy Presseau at npresseau@mednet.ucla.edu.

Overview: The purpose of the NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators. This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees launch competitive, independent research careers. Researchers in the scientific areas of data science and cancer control science are especially encouraged to work with their institutions to apply. For more information, visit the NCI website.

View Full Site